These findings not only enhance our understanding of T-ALL biology but also support the incorporation of NOTCH1/FBXW7 mutation status into contemporary risk stratification models while providing a rationale for the development of novel targeted therapeutic strategies [18]. The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.